0 Members and 1 Guest are viewing this topic.
I gather that the SARS-CoV-2 coronavirus, which causes Covid-19, targets so-called type II pneumocytes, which produce surfactants. So affected parts of the lung can be robbed of surfactant, leading to terminal airway collapse and contributing to the hypoxia that characterises the disease......